Geier, David A.
Geier, Mark R.
Funding for this research was provided by:
Institute of Chronic Illnesses, Inc, United States
Article History
Received: 12 August 2023
Accepted: 1 November 2023
First Online: 21 November 2023
Declarations
:
: Mr. David Geier and Dr. Mark Geier are are small shareholders in EmeraMed, Ltd, which is developing NBMI as treatment for mercury toxicity.